Class I antiarrhythmic agents: Quinidine, procainamide and N-acetylprocainamide, disopyramide
- 1 January 1983
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 23 (2) , 179-191
- https://doi.org/10.1016/0163-7258(83)90012-8
Abstract
No abstract availableThis publication has 65 references indexed in Scilit:
- Interactions with digoxin: more problems.BMJ, 1982
- Therapeutic Drug Monitoring of Antiarrhythmic AgentsClinical Pharmacokinetics, 1982
- Benefits and risks of combined burst pacing and drug therapy of recurrent ventricular tachycardiaThe American Journal of Cardiology, 1981
- Disopyramide pharmacokinetics and bioavailability.Published by Wiley ,1978
- Steady‐state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal functionClinical Pharmacology & Therapeutics, 1978
- Treatment of recurrent ventricular tachycardia and fibrillation with aprindineThe American Journal of Cardiology, 1977
- Cumulation of N‐acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal functionClinical Pharmacology & Therapeutics, 1977
- Interaction of Quinidine with Anticonvulsant DrugsNew England Journal of Medicine, 1976
- Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphateThe American Journal of Cardiology, 1975
- Hemodynamic interaction of procainamide and lidocaine after experimental myocardial infarctionThe American Journal of Cardiology, 1973